Skip to main content

Table 2 Breakdown of All Antimicrobials Prescribed for Outpatient Parenteral Antimicrobial Therapy

From: Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study

Antimicrobial

Total

(N = 200)

Readmitted

(n = 42)

Not Readmitted

(n = 158)

Penicillins

31 (15.5)

10 (23.8)

21 (13.3)

 Ampicillin

4 (12.9)

1 (10)

3 (14.3)

 Ampicillin/sulbactam

6 (19.3)

4 (40)

2 (9.5)

 Nafcillin

5 (16.1)

0 (0)

5 (23.8)

 Oxacillin

3 (9.7)

2 (20)

1 (4.76)

 Penicillin G (parenteral/aqueous)

6 (19.3)

1 (10)

5 (23.8)

 Piperacillin/tazobactam

7 (22.6)

2 (20)

5 (23.8)

Cephalosporins

81 (40.5)

13 (31.0)

68 (43.0)

 Cefazolin

12 (14.8)

3 (23.1)

9 (13.2)

 Cefepime

22 (27.2)

2 (15.4)

20 (29.4)

 Ceftaroline fosamil

6 (7.4)

1 (7.7)

5 (7.4)

 Ceftazidime

3 (3.7)

0 (0)

3 (4.4)

 Ceftriaxone

38 (46.9)

7 (53.8)

31 (45.6)

Carbapenemsa

46 (23)

8 (19.0)

38 (24.1)

 Ertapenem

30 (65.2)

4 (50)

26 (68.4)

 Imipenem/cilastatin

3 (6.5)

0 (0)

3 (7.9)

 Meropenem

14 (30.4)

4 (50)

10 (26.3)

Aminoglycosides (gentamicin)

1 (0.5)

0 (0)

1 (0.6)

Fluoroquinolones (ciprofloxacin)

2 (1)

0 (0)

2 (1.3)

Clindamycin

1 (0.5)

0 (0)

1 (0.6)

Daptomycin

5 (2.5)

2 (4.8)

3 (1.9)

Metronidazole

2 (1)

0 (0)

2 (1.3)

Vancomycin

62 (31)

12 (28.6)

50 (31.6)

Antivirals

4 (2)

1 (2.4)

3 (1.9)

 Acyclovir

2 (50)

0 (0)

2 (66.7)

 Foscarnet

2 (50)

1 (100)

1 (33.3)

  1. All values expressed as n (%)
  2. aOne patient received both meropenem and ertapenem (to start ertapenem after course of meropenem complete)